Likewise, Medicaid gross spending on GLP-1s increased from nearly $1 billion in 2019 to $8.6 billion 2024.
And, as of now, eloralintide does not have a brand name
If you and your clinician decide to stop, the practical approach is: Step down through the available dose levels at 4-week intervals (12 mg 9 mg 6 mg 4 mg 2 mg off) rather than stopping abruptly
As an independent agent, youve probably fielded more than a few phone calls lately from clients stressing over the sky-high costs of weight-loss medications like Wegovy or Zepbound
In the newest campaign, Serena Williams helps to set the record straight on GLP-1s - they're not a shortcut, they're healthcare
GLP-1 Patch delivers a science-backed, non-medicated solution to appetite control and weight management